Thermo Fisher Scientific Inc (TMO) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access TMO quarterly Cash Flow →
A period-by-period view of cash flow from Thermo Fisher Scientific Inc to Dec 31 2021 helps clarify how Dec 31 2025's cash position has changed over time.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2025)
12 Months
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Operating Activities
Income6,721.00
Depreciation & amortization1,050.00
Amortization of Other Assets1,730.00
Extraordinary item0.00
Restructuring reserve0.00
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories-74.00
Minority interest0.00
Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal0.00
Share-based Compensation268.00
Income from affiliates0.00
Gains (Losses) on Extinguishment of Debt0.00
Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Net Of Tax-
Discontinued Operation Gain Loss On Disposal Net Of Tax-
Increase Decrease In Operating Capital Excluding Deferred Taxes-375.00
Income taxes-639.00
Losses/ -gains on investments net0.00
Increase (Decrease) in Accounts Receivable-426.00
Increase (Decrease) in Accounts Payable421.00
Accrued expenses0.00
Post-retirement benefits expense0.00
Increase (Decrease) in Deferred Income Taxes0.00
Other Working Capital-1,312.00
Other Noncash Income (Expense)455.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities-1.00
Discontinued operations0.00
Net Cash flow from Operating Activities7,818.00
Investing Activities
Capital Expenditures-1,525.00
Sale of Capital Items44.00
Short-term investments liq.0.00
Short-term investments acq.0.00
Derivative instruments0.00
Proceeds From Payments For Cross Currency Interest Rate Swap Interest Settlements268.00
Increase (Decrease) in Restricted Cash0.00
Noncontrolling interest0.00
Proceeds from Investments0.00
Payments for (Proceeds from) Other Investments1,182.00
Purchases of non-current assets0.00
Payments to Acquire Businesses, Net of Cash Acquired-4,037.00
Investment in affiliate0.00
Proceeds from Divestiture of Businesses, Net of Cash Divested0.00
Proceeds from sale of assets0.00
Notes receivable0.00
Payments for (Proceeds from) Other Investing Activities21.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-4,047.00
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings7,759.00
Long-term debt - repayments-2,412.00
Noncontrolling interest0.00
Issuances / -repurchases of Comm. Stock-3,000.00
Exercise of stock options0.00
Issuances / -repurchases of Pref. Stock0.00
Discontinued Operations0.00
Other financing activities net0.00
Other net90.00
Dividends paid to minority interests0.00
Dividends paid-636.00
Net Cash Flow from Financing Activities1,801.00
Effect of exchange rate on cash flow267.00
Discontinued operations0.00
Free Cash Flow6,337.00
Total Cash Flow5,839.00
4 historic quarters locked

Sign in to unlock the full Thermo Fisher Scientific Inc cash flow history.

About Thermo Fisher Scientific Inc Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-K filings and normalized by CSIMarket.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: February 26, 2026
  • Source: tmo-20251231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0000097745-26-000018

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document





                    
Get the full CSIMarket dataset: Subscribe API License